With 40% of Agentic AI Projects Predicted to Fail, Leading Software Developer Says Compliance Is the One Place Where Agentic AI Will Thrive
2.12.2025 01:01:00 CET | Business Wire | Press release
Ideagen's CEO explains why binary outcomes and high stakes make compliance ideal for autonomous AI
The CEO of one of the world’s leading global compliance software developers, Ideagen, has today (December 2, 2025) said compliance represents the one domain where autonomous AI will succeed – despite technology insights company Gartner® warning "… over 40% of agentic AI projects will be canceled by the end of 2027”.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251201511477/en/

Ben Dorks, Ideagen CEO
Speaking at the launch of their own agentic AI platform Ideagen Mazlan, Ben Dorks said: “Autonomous AI will succeed in compliance because failure is measurable, stakes are high and outcomes are binary.
“AI that continuously monitors jurisdictional or industry specific compliance frameworks, detects patterns across thousands of records, raises actions for others to follow, flags gaps before audits, autonomously? That's agentic. It will literally save lives and is the most transformative shift in protecting people, products and processes we have ever seen.”
Initial piloting has demonstrated significant acceleration in adoption and benefit, in some cases squeezing 30 minute-tasks down to just two minutes. More significantly, estimates show that enterprise level implementation that could take a company six to nine months, could be achieved in around 30 days.
“In the new year, we’ll be adding things like a voice interface so workers on the frontline, who might be in heavy PPE, can just tell Mazlan what’s happened,” said Dorks.
“And it’s intuitive, people won’t need to be trained to use it. If we can break down barriers to the adoption of digital solutions, then businesses are operating with better data which in turn results in the safer products and processes and a better return on that investment.”
Ideagen achieved the highest score for its AI integration in the 2025 Verdantix Green quadrant with Christopher Sayers, Senior Analyst at Verdantix stating: “Businesses seeking efficiency and safety improvements will find benefits in Ideagen’s pervasive use of AI.”
Ideagen Mazlan was also highlighted in Verdantix’s recent Future of AI-Enabled EHS Software Solutions: “These developments signal a broader shift towards AI that is not just assistive but increasingly capable of autonomously managing compliance and safety risks across complex environments.”
Dorks was also quick to stress that Ideagen Mazlan is not a bolt-on solution to increase productivity: “It’s intelligence, built in. Most 'agentic AI' isn't agentic at all – it's assistive AI with better marketing! AI that accurately answers questions when you ask them? That's a chatbot.
“Our agentic AI works on three simple principles: it's built into Ideagen solutions, it understands your specific industry context and appears naturally throughout your workflows.
“It knows OSHA, ISO and the legislation in your jurisdiction, it knows your own policies and data then uses this to analyze incidents, identifying risks, automating compliance tasks.
“But crucially, like autopilot technology on planes, we’ve built it to ensure that the power still sits with the human. Final oversight and approval remains with the quality managers and health and safety teams, but Mazlan is autonomously doing the heavy lifting.
“I’ll be honest, we could have gone further, but the world isn’t ready for that yet, agentic AI still needs to earn humanity’s trust before we give it full control. But what it can do to keep workplaces safe, reduce product recalls, keep supply chains moving, prevent harmful contaminants entering food? It’s mind blowing.”
Ideagen is one of the world’s leading providers of governance risk and compliance software (GRC) offering the widest spectrum of compliance solutions of any provider covering health and safety, quality, risk, audit, productivity and environmental monitoring.
Its customers include 75% of the top global pharmaceutical companies, more than 250 airlines, nine of the top 10 global aerospace and defense corporations, more than a third of the world’s automotive companies, nine of the top 10 global accounting firms, 65% of the world’s top food and beverage brands and over 2,000 government organizations, hospitals and healthcare centers.
Find out more about Mazlan at Ideagen.ai
View source version on businesswire.com: https://www.businesswire.com/news/home/20251201511477/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom